Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Lantheus Holdings (NQ: LNTH )

24.62 USD -0.20 (-0.81%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 643,046
Open 24.94
Bid (Size) 24.00 (30)
Ask (Size) 25.00 (7)
Prev. Close 24.82
Today's Range 24.54 - 24.94
52wk Range 10.52 - 25.79
Shares Outstanding 67,486,935
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Lantheus To Present Piflufolastat F 18 Data at the Virtual Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2021 Annual Meeting
Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative imaging diagnostics, targeted therapeutics and artificial... 
From Business Wire News Releases
Lantheus Receives U.S. FDA Approval of PYLARIFY® (piflufolastat F 18) Injection, the First and Only Commercially Available PSMA PET Imaging Agent for Prostate Cancer
Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence... 
From Business Wire News Releases

Performance

YTD
+78.79%
+78.79%
1 Month
+18.25%
+18.25%
3 Month
+22.85%
+22.85%
6 Month
+65.79%
+65.79%
1 Year
+72.41%
+72.41%

More News

Read More
Why Lantheus Holdings' Stock Is Trading Higher Today
Tags Movers BZI/WIIM LNTH
From Benzinga
Lantheus Holdings Announces Presentation Featuring 18F-DCFPyL PET/CT, its PSMA-Targeted Prostate Cancer Imaging Agent at the 2021 ASCO Annual Meeting
From Business Wire News Releases
12 Health Care Stocks Moving In Thursday's Intraday Session
Tags LNTH Top Gainers ANPC
From Benzinga
Lantheus Holdings to Present at the Jefferies Virtual Healthcare Conference
From Business Wire News Releases
Lantheus Shares Trading Higher On FDA Approval For Imaging Agent For Identification Of Prostate Cancer
Tags Market News Briefs Health Care
From Benzinga
Stocks Showing Rising Market Leadership: Lantheus Earns 85 RS Rating
From Investor's Business Daily
Thinking about buying stock in Vertex Energy, Lantheus, Tellurian, Tecnoglass, or Pieris Pharmaceuticals?
From PR Newswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Tags ZSAN Pre/Market Outlook Benzinga
From Benzinga
Why Lantheus Stock Is Soaring Today
Tags Market News LNTH
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]